DECISION OF THE EEA JOINT COMMITTEE

No 17/2018

of 9 February 2018

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/2053]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (1) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (2) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (3) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 12 (4) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (5) is to be incorporated into the EEA Agreement.

(6) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1 The following points are inserted after point 20 (Commission Implementing Decision (EU) 2017/1532) of Chapter XV of Annex II to the EEA Agreement: ‘21. 32017 R 2001: Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (OJ L 290, 9.11.2017, p. 1). 22. 32017 R 2002: Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (OJ L 290, 9.11.2017, p. 4). 23. 32017 R 2003: Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (OJ L 290, 9.11.2017, p. 7). 24. 32017 R 2004: Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 12 (OJ L 290, 9.11.2017, p. 11). 25. 32017 R 2005: Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (OJ L 290, 9.11.2017, p. 14).’

Article 2 The texts of Implementing Regulations (EU) 2017/2001, (EU) 2017/2002, (EU) 2017/2003, (EU) 2017/2004 and (EU) 2017/2005 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3 This Decision shall enter into force on 10 February 2018, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 9 February 2018. For the EEA Joint Committee The President Claude MAERTEN

(1) OJ L 290, 9.11.2017, p. 1.

(2) OJ L 290, 9.11.2017, p. 4.

(3) OJ L 290, 9.11.2017, p. 7.

(4) OJ L 290, 9.11.2017, p. 11.

(5) OJ L 290, 9.11.2017, p. 14.

(*1) No constitutional requirements indicated.